A Single Arm Phase II Study of Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma: Interim Biopsy Analysis to Determine Efficacy. Acronym: NivoMes Study
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- Acronyms NivoMes
- 13 Sep 2017 Status changed from active, no longer recruiting to completed.
- 27 Feb 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 17 Jul 2015 New trial record